4 results match your criteria: "From the Radboud University Nijmegen[Affiliation]"
QJM
November 2014
From the Radboud University Nijmegen, Faculty of Medical Sciences, Nijmegen, The Netherlands.
J Rheumatol
July 2014
From the Radboud University Nijmegen Medical Centre, Nijmegen; University of Twente, Enschede; TweeSteden Ziekenhuis, Tilburg; and Medisch centrum Leeuwarden, Leeuwarden, the Netherlands.S.H.M. Manders, MSc; W. Kievit, PhD, Radboud University Nijmegen Medical Centre; A.L.M.A. Braakman-Jansen, PhD, University of Twente; H.L.M. Brus, PhD, TweeSteden Ziekenhuis; L. Hendriks, MSc, Medisch centrum Leeuwarden; J. Fransen, PhD, Radboud University Nijmegen Medical Centre; M.A.F.J. van de Laar, Professor, University of Twente; and P.L.C.M. van Riel, Professor, Radboud University Nijmegen Medical Centre.
Objective: Reduced work participation (WP) is a common problem for patients with rheumatoid arthritis (RA) and generates high costs for society. Therefore, it is important to explore determinants of WP at the start of tumor necrosis factor inhibitor (TNFi) treatment, and for changes in WP after 2 years of TNFi treatment.
Methods: Within the Dutch Rheumatoid Arthritis Monitoring (DREAM) biologic register, WP data were available from 508 patients with RA younger than 65 years and without an (early) retirement pension.
Invest Radiol
September 2014
From the *Radboud University Nijmegen Medical Centre, Department of Radiology, Nijmegen, the Netherlands; †Siemens Medical Solutions, New York, NY; and ‡FraunHofer MEVIS, Bremen, Germany.
Objectives: The use of breast magnetic resonance imaging (MRI) as screening tool has been stalled by high examination costs. Scan protocols have lengthened to optimize specificity. Modern view-sharing sequences now enable ultrafast dynamic whole-breast MRI, allowing much shorter and more cost-effective procedures.
View Article and Find Full Text PDFObstet Gynecol
July 2011
From the Radboud University Nijmegen Medical Centre, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands; Rijnstate Hospital, Department of Obstetrics and Gynecology, Arnhem, the Netherlands; Canisius-Wilhelmina Hospital, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands; Gelderse Vallei Hospital, Department of Obstetrics and Gynecology, Ede, the Netherlands; and Bernhoven Hospital, Department of Obstetrics and Gynecology, Oss, the Netherlands.
Objective: To determine the factors that influence the use of frozen section analysis in adnexal masses and the factors that predict malignancy.
Methods: The study participants were women scheduled for adnexal mass surgery in 11 hospitals between 2005 and 2009. Factors that potentially influenced the use of frozen section analysis and potentially predicted malignancy were studied, such as menopausal status, CA 125 level, ultrasound characteristics, presence of adhesions, and tumor size.